Vaccine vector for new diseases {#cesec10}
===============================

Pretested, attenuated [vaccine vectors](10.1073/pnas.0703584104) might expedite vaccine development against the new pathogens that regularly threaten human health. A recent study identifies Newcastle disease virus (NDV), an avian paramyxovirus that is highly attenuated in primates, as a potential vaccine vector. African green monkeys were given two intranasal doses of NDV expressing the spike S glycoprotein of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) before challenge with SARS-CoV. At the peak of viral replication, the vaccinated animals had much lower viral titres in their lungs than control animals.

Passive influenza protection... {#cesec20}
===============================

Highly pathogenic H5N1 avian influenza, which has so far killed about 60% of the people it has infected, could trigger a human influenza pandemic at any time. Now, new research suggests that [passive immunisation](10.1371/journal.pmed.0040178) with neutralising human monoclonal antibodies (mAbs) might be useful prophylactically and therapeutically. Researchers immortalised memory B cells from Vietnamese adults who had recovered from infection with H5N1 and screened these cells for the production of mAbs that neutralised the virus. The four mAbs generated in this way protected mice from the lethal effects of several strains of H5N1.

...and active HIV-1 vaccination {#cesec30}
===============================

Researchers may have discovered an immunisation regimen that induces cross-reactive neutralising [antibodies against HIV-1](10.1073/pnas.0608635104). The scientists injected rabbits with the adjuvant AS02A (an oil in water emulsion) and a soluble, oligomeric preparation of the HIV envelope protein variant (gp140~R2~) derived from an HIV-1-infected individual who made neutralising antibodies against several HIV subtypes. This immunogen--adjuvant mix induced moderately potent antibodies that neutralised all 48 HIV-1 subtypes tested. These results are encouraging because they show that a broad antibody response can be raised against HIV-1.

Genetic AIDS protection {#cesec40}
=======================

The variability in the [rate of progression to AIDS](10.1038/ng2035) after infection with HIV-1 remains largely unexplained. Now, though, researchers report that specific combinations of two components of the innate immune response---natural killer cell immunoglobulin receptors (KIRs) and their ligands, HLA-B molecules---strongly influence AIDS progression. The researchers reached this conclusion by examining *KIR3DL1* and *HLA-B l*oci in 1500 HIV-1-positive individuals. As well as helping to explain the variability of AIDS progression, these new results underline the importance of natural killer cells in fighting HIV-1 infections.

Deadly HIV-1 and malaria duo {#cesec50}
============================

Primigravid women are vulnerable to pregnancy-associated malaria (PAM) but become resistant to it during subsequent pregnancies. HIV infection interferes with this protection (which is associated with the production of immunoglobulins against variant surface antigens, VSA-PAM-specific IgG), but how? [A new study reveals](10.1371/journal.pmed.0040181) that VSA-PAM-specific IgGs protect against PAM by stimulating the opsonisation (ingestion) of parasitised erythrocytes by phagocytes. Plasma from HIV-positive multigravid women, however, contains less VSA-PAM-specific IgG and less opsonising activity than that from HIV-negative multigravid women, which could explain why HIV infection increases the risk of PAM in these women.

DC-SIGN for HIV spread {#cesec60}
======================

The initiation of an immune response requires activation of dendritic cells, the cells that HIV uses to enter the human body. To gain access to dendritic cells, HIV binds to the C-type lectin DC-SIGN. Now, [expression profiling and analysis](10.1038/ni1470) of the tyrosine-phosphorylated proteome show that HIV binding to DC-SIGN elicits a signalling pathway that induces an immature dendritic cell phenotype. Because this phenotype cannot actively stimulate an immune response, the HIV--DC-SIGN interaction helps HIV to evade the immune response. Additionally, the study shows that this interaction helps HIV spread into T cells.
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*Clostridium botulinum* genome {#cesec70}
==============================

The Gram-positive species *Clostridium botulinum* contains four distinct groups of bacteria, all of which make botulinum neurotoxin. Group I (proteolytic) strains cause most cases of food-borne, infant, and wound botulism and now [scientists have completely sequenced](10.1101/gr.6282807) a representative of this group. The genome sequence indicates that, unlike many pathogens, *C botulinum* does not manipulate its hosts\' biology to ensure its survival. Instead, it uses its toxin to kill its prey, destroys the rotting tissues by releasing extracellular enzymes (including proteinases and chitinases), and then hoovers up its food using its large repertoire of enzymes involved in aminoacid and sugar uptake and metabolism.
